A drug interaction occurs when one drug modifies the effect of another — altering its absorption, distribution, metabolism, elimination, or mechanism of action. Drug interactions can increase a drug’s effect (potentiation), decrease it (antagonism), or produce effects that neither drug produces alone.
Pharmacokinetic interactions
These occur when one drug alters the pharmacokinetics of another:
Absorption interactions — one drug alters the absorption of another. Antacids raise gastric pH, reducing the absorption of drugs that require acid for dissolution. Calcium supplements bind to certain antibiotics (tetracyclines, fluoroquinolones) in the gut, forming insoluble complexes that cannot be absorbed.
Metabolic interactions — the most clinically significant category. The cytochrome P450 (CYP) enzyme system in the liver metabolizes the majority of drugs. One drug can:
- Inhibit a CYP enzyme, slowing the metabolism of every other drug processed by that enzyme. The inhibited drug accumulates, potentially reaching toxic levels at standard doses. Example: fluconazole inhibits CYP3A4, increasing levels of drugs metabolized by CYP3A4 (including some benzodiazepines, statins, and calcium channel blockers).
- Induce a CYP enzyme, accelerating the metabolism of every other drug processed by that enzyme. The induced drug is cleared faster, potentially falling below therapeutic levels. Example: rifampin is a potent CYP3A4 inducer that can reduce the levels of oral contraceptives below effective concentrations — a drug interaction with significant consequences that may not be apparent until pregnancy occurs.
Elimination interactions — one drug alters the renal or biliary excretion of another. Probenecid blocks the renal tubular secretion of penicillin, increasing penicillin levels. Lithium and NSAIDs interact through renal sodium handling — NSAIDs reduce renal lithium clearance, raising lithium levels toward toxicity.
Pharmacodynamic interactions
These occur when drugs interact at the receptor or physiological level:
Additive effects — two drugs acting on the same system produce a combined effect equal to the sum of their individual effects. Two different sedatives each producing moderate sedation together produce heavy sedation.
Synergistic effects — the combined effect exceeds the sum of individual effects. The combination of opioids and benzodiazepines produces respiratory depression far greater than either drug alone — a synergistic interaction responsible for a significant proportion of overdose deaths.
Antagonistic effects — one drug opposes the effect of another. Naloxone reverses opioid effects by competitive antagonism at the mu-opioid receptor. Flumazenil reverses benzodiazepine effects by competitive antagonism at the GABA-A receptor. These antagonistic interactions are the pharmacological basis of overdose reversal.
Drug interactions and harm reduction
The opioid-benzodiazepine interaction is one of the most lethal drug interactions encountered in clinical practice and in the community. Both drug classes depress the brainstem respiratory centers, and their combined effect on respiratory drive is synergistic, not merely additive. This interaction kills through a mechanism that neither drug’s individual dose-response curve predicts — a person who tolerates a given dose of opioid alone and a given dose of benzodiazepine alone may die from the combination.
Harm reduction programs address this interaction through:
- Education — informing people who use opioids about the specific dangers of combining with benzodiazepines, alcohol, or other CNS depressants
- Naloxone distribution — providing opioid antagonist for overdose reversal
- Supervised consumption — providing settings where polysubstance interactions can be monitored and reversed
- Prescriber awareness — the coprescribing of opioids and benzodiazepines, which remains common in clinical practice, represents an iatrogenic drug interaction that guidelines increasingly warn against
Drug-food and drug-herb interactions
Interactions are not limited to prescription drugs. Grapefruit juice inhibits intestinal CYP3A4, increasing bioavailability of drugs normally partly metabolized in the gut wall. St. John’s Wort induces CYP3A4, reducing levels of oral contraceptives, warfarin, and many other drugs. TCM herbal formulas — which may contain dozens of pharmacologically active compounds — interact with Western pharmaceuticals through mechanisms that are often unstudied.
Related terms
- Pharmacokinetics — the ADME processes where pharmacokinetic interactions occur
- Pharmacodynamics — the receptor-level mechanisms where pharmacodynamic interactions occur
- Therapeutic Index — the margin of safety that drug interactions can narrow or eliminate